Involvement of epidermal growth factor receptor overexpression in the promotion of breast cancer brain metastasis

Cancer

Volumn 118, Issue 21, 2012, Pages 5198-5209

  Nie, Fang ^a   Yang, Jian ^b   Wen, Song ^a   An, Yan Li ^a   Ding, Jie ^a   Ju, Sheng Hong ^a   Zhao, Zhen ^a   Chen, Hua Jun ^a   Peng, Xin Gui ^a   Wong, Stephen T C ^b   Zhao, Hong ^b   Teng, Gao Jun ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

brain metastasis; breast cancer; cell migration; epidermal growth factor receptor; proliferation

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C GAMMA; PROTEIN KINASE B; SHORT HAIRPIN RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN METASTASIS; BREAST CANCER; CANCER CELL CULTURE; CANCER INVASION; CELL ADHESION; CELL ASSAY; CELL CYCLE; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOCHEMISTRY; CYTOSKELETON; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; WOUND HEALING;

ANIMALS; BRAIN NEOPLASMS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; MICE, NUDE; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSPLANTATION, HETEROLOGOUS;

EID: 84866341984     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27553     Document Type: Article

References (40)

1. Weil RJ, Palmieri DC, Bronder JL, Stark AM, Steeg PS,. Breast cancer metastasis to the central nervous system. Am J Pathol. 2005; 167: 913-920.
2. Patel RR, Mehta MP,. Targeted therapy for brain metastases: improving the therapeutic ratio. Clin Cancer Res. 2007; 13: 1675-1683.
3. Grewal J, Kesari S,. Breast cancer surface receptors predict risk for developing brain metastasis and subsequent prognosis [serial online]. Breast Cancer Res. 2008; 10: 104.
4. Gril B, Evans L, Palmieri D, Steeg PS,. Translational research in brain metastasis is identifying molecular pathways that may lead to the development of new therapeutic strategies. Eur J Cancer. 2010; 46: 1204-1210.
5. Lorger M, Felding-Habermann B,. Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis. Am J Pathol. 2010; 176: 2958-2971.
6. Nguyen DX, Bos PD, Massague J,. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 2009; 9: 274-284.
7. Bos PD, Zhang XH, Nadal C, et al. Genes that mediate breast cancer metastasis to the brain. Nature. 2009; 459: 1005-1009.
8. Hicks DG, Short SM, Prescott NL, et al. Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR. Am J Surg Pathol. 2006; 30: 1097-1104.
9. Palmieri D, Bronder JL, Herring JM, et al. Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain. Cancer Res. 2007; 67: 4190-4198.
10. Tham YL, Sexton K, Kramer R, Hilsenbeck S, Elledge R,. Primary breast cancer phenotypes associated with propensity for central nervous system metastases. Cancer. 2006; 107: 696-704.
11. Klein A, Olendrowitz C, Schmutzler R, et al. Identification of brain- and bone-specific breast cancer metastasis genes. Cancer Lett. 2009; 276: 212-220.
12. Hynes NE, Lane HA,. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer. 2005; 5: 341-354.
13. Mishani E, Abourbeh G, Eiblmaier M, Anderson CJ,. Imaging of EGFR and EGFR tyrosine kinase overexpression in tumors by nuclear medicine modalities. Curr Pharm Des. 2008; 14: 2983-2998.
14. Abd El-Rehim DM, Pinder SE, Paish CE, et al. Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma. Br J Cancer. 2004; 91: 1532-1542.
15. Giltnane JM, Moeder CB, Camp RL, Rimm DL,. Quantitative multiplexed analysis of ErbB family coexpression for primary breast cancer prognosis in a large retrospective cohort. Cancer. 2009; 115: 2400-2409.
16. Viale G, Rotmensz N, Maisonneuve P, et al. Invasive ductal carcinoma of the breast with the "triple-negative" phenotype: prognostic implications of EGFR immunoreactivity. Breast Cancer Res Treat. 2009; 116: 317-328.
17. O'Donovan N, Crown J,. EGFR and HER-2 antagonists in breast cancer. Anticancer Res 27 (3A): 1285-1294, 2007.
18. Saxena R, Dwivedi A,. ErbB family receptor inhibitors as therapeutic agents in breast cancer: current status and future clinical perspective. Med Res Rev. 2012; 32: 166-215.
19. Yoneda T, Williams PJ, Hiraga T, Niewolna M, Nishimura R,. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J Bone Miner Res. 2001; 16: 1486-1495.
20. Gril B, Palmieri D, Bronder JL, et al. Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain. J Natl Cancer Inst. 2008; 100: 1092-1103.
21. Zhao H, Cui K, Nie F, et al. The effect of mTOR inhibition alone or combined with MEK inhibitors on brain metastasis: an in vivo analysis in triple-negative breast cancer models. Breast Cancer Res Treat. 2011; 131: 425-436.
22. Takenawa T, Yamazaki D, Kurisu S,. Regulation of cancer cell motility through actin reorganization. Cancer Sci. 2005; 96: 379-386.
23. Yamaguchi H, Condeelis J,. Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta. 2007; 1773: 642-652.
24. Giese A, Loo MA, Tran N, Haskett D, Coons SW, Berens ME,. Dichotomy of astrocytoma migration and proliferation. Int J Cancer. 1996; 67: 275-282.
25. Fedotov S, Iomin A,. Migration and proliferation dichotomy in tumor-cell invasion. Phys Rev Lett. 2007; 98: 118101-118101.
26. Farquhar MG, Ghosh P, Beas AO, et al. A G alpha i-GIV molecular complex binds epidermal growth factor receptor and determines whether cells migrate or proliferate. Mol Biol Cell. 2010; 21: 2338-2354.
27. Kwiatkowski DJ, Azuma T, Witke W, Stossel TT, Hartwig JH,. Gelsolin is a downstream effector of rac for fibroblast motility. EMBO J. 1998; 17: 1362-1370.
28. Arora PD, McCulloch CA,. Dependence of fibroblast migration on actin severing activity of gelsolin. J Biol Chem. 1996; 271: 20516-20523.
29. McCubrey JA, Lahair MM, Franklin RA,. Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid Redox Signal. 2006; 8: 1775-1789.
30. Warnberg F, White D, Anderson E, et al. Effect of a farnesyl transferase inhibitor (R115777) on ductal carcinoma in situ of the breast in a human xenograft model and on breast and ovarian cancer cell growth in vitro and in vivo [serial online]. Breast Cancer Res. 2006; 8: R2.
31. Neman J, Somlo G, Jandial R,. Classification of genomic changes in breast cancer brain metastasis. Neurosurgery. 2010; 67: N18-N19.
32. Smid M, Wang Y, Zhang Y, et al. Subtypes of breast cancer show preferential site of relapse. Cancer Res. 2008; 68: 3108-3114.
33. Lin NU, Claus E, Sohl J, Razzak AR, Arnaout A, Winer EP,. Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases. Cancer. 2008; 113: 2638-2645.
34. Livasy CA, Karaca G, Nanda R, et al. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol. 2006; 19: 264-271.
35. Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res. 2004; 10: 5367-5374.
36. Da Silva L, Simpson PT, Smart CE, et al. HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer [serial online]. Breast Cancer Res. 2010; 12: R46.
37. Kim LS, Huang S, Lu W, Lev DC, Price JE,. Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice. Clin Exp Metastasis. 2004; 21: 107-118.
38. Lai R, Dang CT, Malkin MG, Abrey LE,. The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma. Cancer. 2004; 101: 810-816.
39. Lin NU, Winer EP,. Brain metastases: the HER2 paradigm. Clin Cancer Res. 2007; 13: 1648-1655.
40. Minn AJ, Gupta GP, Siegel PM, et al. Genes that mediate breast cancer metastasis to lung. Nature. 2005; 436: 518-524.